Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Condition(s):Anal High-grade Squamous Intraepithelial Lesion; Anal HSIL; Anal HPV InfectionLast Updated:February 22, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Anal High-grade Squamous Intraepithelial Lesion; Anal HSIL; Anal HPV InfectionLast Updated:February 22, 2024Recruiting
Condition(s):Vulvar Diseases; HPV Infection; Vulvar HSIL; Pre-Cancerous Dysplasia; HPV Disease; VIN, Usual Type; VIN 2 of Usual Type; VIN 3 of Usual Type; Vin II; Vin III; VIN Grade 2; VIN Grade 3; High Grade Intraepithelial NeoplasiaLast Updated:February 21, 2024Recruiting
Condition(s):Anal High Grade Squamous Intraepithelial Lesion; Anal Precancerous Condition; AIN 2/3; HPV Infection; Anal Dysplasia; HPV DiseaseLast Updated:February 21, 2024Active, not recruiting
Condition(s):CIN 2/3; HPV Infection; Pre-Cancerous Dysplasia; Cervical Dysplasia; HPV Related DiseaseLast Updated:February 21, 2024Recruiting
Condition(s):Vulvar Dysplasia; HPV-Related Vulvar Intraepithelial Neoplasia; Preinvasive Vulvar Disease; Vulva Intraepithelial Neoplasia; Vulvar DiseasesLast Updated:November 7, 2023Active, not recruiting
Condition(s):HPV-Related Anal Intraepithelial Neoplasia; AIN2/3; Artesunate; Alternative Treatment; Anal Dysplasia; Precancerous Conditions; Human Papilloma VirusLast Updated:November 3, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.